BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200206
DTEND;VALUE=DATE:20200208
DTSTAMP:20260515T060758
CREATED:20191031T095454Z
LAST-MODIFIED:20191031T104545Z
UID:23112-1580947200-1581119999@www.pharmajournalist.com
SUMMARY:4th Edition MarketsandMarkets Genome Editing & Gene Therapy Conference
DESCRIPTION:Since our past editions we dedicated our focus on the latest developments and addressed various applications of CRISPR as a molecular tool\, gene expression\, knock-in\, genomic screening\, along with therapeutic developments through animal modeling. Attended by 100+ genome editing professionals and 20+ gene expert speakers\, the event saw participation of big companies like Casebia Therapeutics\, Genentech\, BMS\, Cellectis \, University of Laval\, University of California\, Center of Advanced Genome Engineering\, Georgia Tech\, Stanford University\, Locana\, Harvard Medical School\, Agility\, Poseida\, Vertex\, Ligandal\, Integrated DNA Technologies\, GE Healthcare\, Cellecta\, Agilent\, Advanced Analytical\, Thermofisher\, Atum\, Synthego\, New England Biolabs\, Aldevron\, Applied Stem Cell and more. \n \nIn 2020\, coming with the 4th Edition MarketsandMarkets Genome Editing & Gene Therapy Conference on 6th & 7th February in San Diego\, we are getting ahead by discussing the commercialization and advancements of technology which will outline breakthrough advancements in pre-clinical & clinical therapeutics using genome Editing. The event will also focus on analysis of off target effects\, specificity and aspects of gene and cellular therapies. \nTo learn more about 4th Edition MarketsandMarkets Genome Editing & Gene Therapy Conference click here
URL:https://www.pharmajournalist.com/event/4th-edition-marketsandmarkets-genome-editing-gene-therapy-conference/
LOCATION:San Diego\, CA
ORGANIZER;CN="MarketsandMarkets Research Private Ltd.":MAILTO:suraj.waghmare@marketsandmarkets.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200206
DTEND;VALUE=DATE:20200208
DTSTAMP:20260515T060758
CREATED:20191031T101817Z
LAST-MODIFIED:20191031T101817Z
UID:23125-1580947200-1581119999@www.pharmajournalist.com
SUMMARY:5th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference
DESCRIPTION:The 5th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 6th – 7th February 2020 in San Diego\, CA would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers\, Precision Medicine and Big Data. Regarding commercialization of biomarkers\, leading industry and academic experts would share their case studies focusing on advancements in companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers. \n \nTo learn more about 5th Annual Biomarker and Companion Diagnostics Conference click here
URL:https://www.pharmajournalist.com/event/5th-annual-marketsandmarkets-biomarker-and-companion-diagnostics-conference/
LOCATION:MA
ORGANIZER;CN="MarketsandMarkets Research Private Ltd.":MAILTO:Shardul.oza@marketsandmarkets.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200206
DTEND;VALUE=DATE:20200208
DTSTAMP:20260515T060758
CREATED:20191031T102512Z
LAST-MODIFIED:20191031T104231Z
UID:23129-1580947200-1581119999@www.pharmajournalist.com
SUMMARY:MarketsandMarkets Gen-Next Probiotics and Microbiome Congress
DESCRIPTION:What are the essentials being missed out on? What is the real role of probiotics strains\, prebiotics and symbiotic in influencing a health? How do you standardize microbiome analysis? \nWitness the major breakthroughs of microbiome\, probiotics and prebiotics research along with their applications pertaining to challenges like medicinal data interpretation\, investment and regulatory hurdles faced by the practitioners. The intersection between emerging technology and discovery with the context of consumer interest. Detect the non-identified dysbiosis\, to discover the potential areas under study for investments in Gut and Skin microbiome and its role as a diagnostic tool of pharmaceutical discovery. \n \nJoin us at Gen-Next Probiotics and Microbiome Congress\, 2020 to network with biotech\, pharma\, academicians and investors to exchange views and observe the most ingenious research and technologies. Understand what’s happening. Witness the amalgamation of study focused on pharmaceutical and medicinal approaches of probiotics and the nutraceutical and consumer approaches along with the role of microbiome in clinical applications and preventative medicine. \nTo learn more about MarketsandMarkets Gen-Next Probiotics and Microbiome Congress click here
URL:https://www.pharmajournalist.com/event/marketsandmarkets-gen-next-probiotics-and-microbiome-congress/
LOCATION:San Diego\, CA
ORGANIZER;CN="MarketsandMarkets Research Private Ltd.":MAILTO:suraj.waghmare@marketsandmarkets.com
END:VEVENT
END:VCALENDAR